Microba Life Sciences (ASX:MAP) has announced new agreements with SYNLAB International affiliate organisations to distribute its testing technology in Turkey and Czech Republic.
According to Microba’s senior vice president of services, Bernie Woodcroft, “We continue to progress distribution expansion with SYNLAB, Europe’s largest medical diagnostics company, to drive our testing into the hands of clinicians and patients across Europe. Adding Türkiye and Czech Republic is another positive step forward in the global distribution expansion of Microba’s testing services”.
In 2020, Microba entered into a master agreement with SYNLAB International and an agreement with SYNLAB Diagnosticos Globales to deliver Microba’s testing to Healthcare Providers in Spain, with an option to formalise distribution agreements across their affiliate organisations, which operate in 36 countries.
In response to positive sales and customer feedback in Spain, in October last year, SYNLAB further activated their rights through an amendment to the master agreement with Microba to pursue formal expansion into additional countries across Europe and Latin America.
In December, a first group of new agreements were signed with SYNLAB affiliate organisations for Italy and Portugal, which have now been operationalised and achieved first sales.
The company said that entry into Turkey and Czech Republic represents another positive step and further affiliate country agreements are anticipated in the near term.
